Cargando…
Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010
BACKGROUND: We examined the change in the use of rosiglitazone-containing products (RCPs) Canada-wide between 2004 and 2010 and whether the rates of adverse events in association with RCP therapy in Canadian patients changed in this period to better understand the real world use of RCP medications a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606324/ https://www.ncbi.nlm.nih.gov/pubmed/23497453 http://dx.doi.org/10.1186/1756-0500-6-82 |